Simple fluorinated moiety insertion on Aβ 16-23 peptide for stain-free TEM imaging.

Peptide aggregation and fibre formation are one of the major underlying causes of several neurodegenerative disorders such as Alzheimer's disease. During the past decades the characterisation of these fibres has been widely studied in an attempt to further understand the nature of the related diseases and in an effort to develop treatments. Transmission electron microscopy (TEM) is one of the most commonly used techniques to identify these fibres, but requires the use of a radioactive staining agent. The procedure we report overcomes this drawback through simple addition of a fluorinated moiety to a short Amyloid β sequence via solid phase peptide synthesis (SPPS). This method is synthetically straightforward, widely applicable to different aggregation-prone sequences and, above all, allows for stain-free TEM imaging with improved quality compared to standard imaging procedures. The presence of the fluorinated moiety does not cause major changes in the fibre structure or aggregation, but rather serves to dissipate the microscope's electron beam, thus allowing for high contrast and straightforward imaging by TEM.

[1]  Samuel T. Jones,et al.  A facile method for the stain‐free visualization of hierarchical structures with electron microscopy , 2015 .

[2]  K. Sakaguchi,et al.  Formation of Functionalized Nanowires by Control of Self‐Assembly Using Multiple Modified Amyloid Peptides , 2013 .

[3]  Michele Vendruscolo,et al.  Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism , 2013, Proceedings of the National Academy of Sciences.

[4]  R. Tycko,et al.  Polymorph-specific kinetics and thermodynamics of β-amyloid fibril growth. , 2013, Journal of the American Chemical Society.

[5]  M. Haaparanta,et al.  Oxime formation for fluorine-18 labeling of peptides and proteins for positron emission tomography (PET) imaging: A review , 2012 .

[6]  S. Perrier,et al.  Altering peptide fibrillization by polymer conjugation. , 2012, Biomacromolecules.

[7]  Thomas Schrader,et al.  Lysine-specific molecular tweezers are broad-spectrum inhibitors of assembly and toxicity of amyloid proteins. , 2011, Journal of the American Chemical Society.

[8]  Nikolaus Grigorieff,et al.  Recent progress in understanding Alzheimer's β-amyloid structures. , 2011, Trends in biochemical sciences.

[9]  R. Tycko.  Solid-state NMR studies of amyloid fibril structure. , 2011, Annual review of physical chemistry.

[10]  I. Hamley,et al.  Influence of the solvent on the self-assembly of a modified amyloid beta peptide fragment. II. NMR and computer simulation investigation. , 2010, The journal of physical chemistry. B.

[11]  N. Grigorieff,et al.  Comparison of Alzheimer Aβ(1–40) and Aβ(1–42) amyloid fibrils reveals similar protofilament structures , 2009, Proceedings of the National Academy of Sciences.

[12]  R. P. Cheng,et al.  Effect of highly fluorinated amino acids on protein stability at a solvent-exposed position on an internal strand of protein G B1 domain. , 2009, Journal of the American Chemical Society.

[13]  N. Grigorieff,et al.  Abeta(1-40) fibril polymorphism implies diverse interaction patterns in amyloid fibrils. , 2009, Journal of molecular biology.

[14]  I. Hamley,et al.  Self-assembly in aqueous solution of a modified amyloid beta peptide fragment. , 2008, Biophysical Chemistry.

[15]  N. Grigorieff,et al.  Paired β-sheet structure of an Aβ(1-40) amyloid fibril revealed by electron microscopy , 2008, Proceedings of the National Academy of Sciences.

[16]  E. Gazit,et al.  Controlled patterning of aligned self-assembled peptide nanotubes , 2006, Nature nanotechnology.

[17]  Ehud Gazit,et al.  Fabrication of coaxial metal nanocables using a self-assembled peptide nanotube scaffold. , 2006, Nano letters.

[18]  C. Dobson,et al.  Protein misfolding, functional amyloid, and human disease. , 2006, Annual review of biochemistry.

[19]  C. Glabe.  Common mechanisms of amyloid oligomer pathogenesis in degenerative disease , 2006, Neurobiology of Aging.

[20]  R. Tycko,et al.  Experimental constraints on quaternary structure in Alzheimer's beta-amyloid fibrils. , 2006, Biochemistry.

[21]  Christian Jäckel,et al.  Fluorine in Peptide Design and Protein Engineering , 2005 .

[22]  N. C. Price,et al.  How to study proteins by circular dichroism. , 2005, Biochimica et biophysica acta.

[23]  Martin Stahl,et al.  Fluorine in Medicinal Chemistry , 2004, Chembiochem : a European journal of chemical biology.

[24]  Justin C. Biffinger,et al.  The Polar Hydrophobicity of Fluorinated Compounds , 2004, Chembiochem : a European journal of chemical biology.

[25]  D. Selkoe.  Folding proteins in fatal ways , 2003, Nature.

[26]  Janel O. Johnson,et al.  α-Synuclein Locus Triplication Causes Parkinson's Disease , 2003, Science.

[27]  Shuguang Zhang.  Fabrication of novel biomaterials through molecular self-assembly , 2003, Nature Biotechnology.

[28]  J. Pinkner,et al.  Real-time and equilibrium 19F-NMR studies reveal the role of domain–domain interactions in the folding of the chaperone PapD , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[29]  C. Dobson,et al.  Formation of mixed fibrils demonstrates the generic nature and potential utility of amyloid nanostructures , 2000 .

[30]  R. Leapman,et al.  Amyloid Fibril Formation by Aβ16-22, a Seven-Residue Fragment of the Alzheimer's β-Amyloid Peptide, and Structural Characterization by Solid State NMR† , 2000 .

[31]  J. M. Smith,et al.  Direct visualisation of the beta-sheet structure of synthetic Alzheimer's amyloid. , 2000, Journal of molecular biology.

[32]  L. Kiessling,et al.  Recognition sequence design for peptidyl modulators of beta-amyloid aggregation and toxicity. , 1999, Biochemistry.

[33]  S. Kahn,et al.  Islet amyloid: a long-recognized but underappreciated pathological feature of type 2 diabetes. , 1999, Diabetes.

[34]  S. W. Davies,et al.  Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. , 1997, Science.

[35]  D. Walsh,et al.  Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate. , 1997, The Journal of biological chemistry.

[36]  L. Tjernberg,et al.  Controlling Amyloid β-Peptide Fibril Formation with Protease-stable Ligands* , 1997, The Journal of Biological Chemistry.

[37]  P E Fraser,et al.  Structure of beta-crystallite assemblies formed by Alzheimer beta-amyloid protein analogues: analysis by x-ray diffraction. , 1993, Biophysical journal.

[38]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[39]  R. Leapman,et al.  A structural model for Alzheimer's beta -amyloid fibrils based on experimental constraints from solid state NMR. , 2002, Proceedings of the National Academy of Sciences of the United States of America.